A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints

Annals of Oncology

Volumn 11, Issue 9, 2000, Pages 1165-1170

  Ferry, D R ^a   Deakin, M ^b   Baddeley, J ^a   Daryanani, S ^a   Bramhall, S ^c   Anderson, D A ^a   Wakelam, M J O ^a   Doran, J ^a   Pemberton, G ^a   Young, A M ^a   Buckels, J ^c   Kerr, D J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c University Hospitals Trust   (United Kingdom)

Author keywords

Inhibitor; Lipoxygenase; Pancreatic

Indexed keywords

2,3,5 TRIMETHYL 6 (3 PYRIDYLMETHYL) 1,4 BENZOQUINONE; LIPOXYGENASE INHIBITOR; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; ENZYME INHIBITION; FEMALE; HUMAN; MALE; MYALGIA; PANCREAS CANCER; PHARMACODYNAMICS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0033788030     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008303715515     Document Type: Article

References (16)

1. Incidence, treatment and survival in 13,560 patients with pancreatic cancer: An epidemiological study in the West Midlands
2. Survival after pancreatoduodenectomy; 118 consecutive resections without an operative mortality
3. Cancer of the pancreas 50 years of surgery
4. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin
5. Palliative and adjuvant regional chemotherapy in pancreatic cancer
6. Phase II trial of gemcitabine in patients with adenocarcinoma of the pancreas
7. Phase II study of gemcitabine in patients with advanced pancreatic cancer
8. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomised trial
9. Treatment of pancreatic cancer with docetaxel and granulocyte colony stimulating factor: A multicentre phase II study
10. 2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species, synthesis of a novel series of (3-pyridylmethyl) benzoquinone derivatives
11. Novel antitumour activity of CV6504 against established murine adenocarcinomas
12. Novel therapeutic strategies for colorectal cancer
13. Methodological aspects of phase I studies of novel anticancer agents
14. Phase I trial of the flavonoid, quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition
15. Signalling inhibitors in the clinic: New agents and new challenges